LPCAT3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to LPCAT3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides	PHASE1	COMPLETED
Assessment of Coronary Plaque Composition	PHASE1	COMPLETED
Autotaxin (ATX) as a Marker for Breast Cancer	nan	UNKNOWN
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children	nan	WITHDRAWN
Choline to Improve Malnutrition and Enhance Cognition	nan	RECRUITING
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease	nan	RECRUITING
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes	nan	COMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.	nan	UNKNOWN
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)	nan	UNKNOWN
Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers	nan	COMPLETED
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.	nan	COMPLETED
Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression	nan	COMPLETED
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease	nan	UNKNOWN
Epidemiology of Atherosclerosis	nan	COMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy	nan	COMPLETED
Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure	nan	COMPLETED
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV	nan	NOT_YET_RECRUITING
Genomic Dissection of a QTL Affecting the Lipid Profile	nan	WITHDRAWN
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)	nan	UNKNOWN
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies	nan	UNKNOWN
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing	nan	COMPLETED
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia	nan	UNKNOWN
Precision Medicine for Sng/Pain Control	nan	COMPLETED
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study	nan	COMPLETED
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia	nan	COMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes	nan	COMPLETED
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects	nan	UNKNOWN
Egg Intake, Metabolic Outcomes and Choline Levels	nan	RECRUITING
Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA	nan	UNKNOWN
Omics-based Predictors of NAFLD/Potential NASH	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a LPCAT3 binder may also engage these)

Protein	Name	Similarity
Q91V01	—	1.000	Q91V01 →
Q3SZL3	—	1.000	Q3SZL3 →
Q5FVN0	—	0.998	Q5FVN0 →
Q9VVX5	—	0.989	Q9VVX5 →
O01925	—	0.989	O01925 →
Q5ZKL6	—	0.988	Q5ZKL6 →
Q8BH98	—	0.988	Q8BH98 →
Q3T1J2	—	0.987	Q3T1J2 →
MBOAT1	Membrane-bound glycerophospholipid O-acyltransferase 1	0.985	landscape →
Q8R3I2	—	0.983	Q8R3I2 →
Q6ZWT7	—	0.983	Q6ZWT7 →
A8WXS4	—	0.981	A8WXS4 →
Q9VMD5	—	0.978	Q9VMD5 →
B1Q006	—	0.977	B1Q006 →
Q7SZQ0	—	0.977	Q7SZQ0 →
O42916	—	0.977	O42916 →
Q19468	—	0.976	Q19468 →
Q5U4T9	—	0.973	Q5U4T9 →
Q6NN55	—	0.972	Q6NN55 →
Q08548	—	0.972	Q08548 →
P53154	—	0.971	P53154 →
Q1LZA4	—	0.970	Q1LZA4 →
A0A0P0WY03	—	0.970	A0A0P0WY03 →
Q09758	—	0.969	Q09758 →
Q60457	—	0.968	Q60457 →
Q7Z7B1	—	0.967	Q7Z7B1 →
O77761	—	0.967	O77761 →
Q6IWY1	—	0.967	Q6IWY1 →
I1MSF2	—	0.967	I1MSF2 →
Q7TSN4	—	0.966	Q7TSN4 →